XML 31 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2019
Revenue Recognition  
Schedule of disaggregation of revenue by test families

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31,

​

​

2019

​

2018

​

2017

(Amounts in thousands)

​

​

​

​

​

​

​

Product revenues

​

​

​

​

​

​

​

​

​

Sale of genetic tests

​

$

269,881

​

$

240,366

​

$

203,777

Licensing and other

​

 

​

​

​

​

​

​

​

Upfront license and Constellation and paternity

​

​

5,089

​

​

10,344

​

​

4,229

License and development services

​

​

16,379

​

​

294

​

​

—

Other

​

​

10,979

​

​

6,650

​

​

1,619

Licensing and other revenues

​

​

32,447

​

​

17,288

​

​

5,848

Total revenues

​

$

302,328

​

$

257,654

​

$

209,625

Schedule of disaggregation of revenue by payer types

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31,

​

​

2019

​

2018

​

2017

(Amounts in thousands)

​

​

​

​

​

​

​

Insurance carriers

​

$

210,919

​

$

193,895

​

$

163,861

Laboratory partners

​

​

59,876

​

​

44,062

​

​

36,001

Patients

​

​

31,533

​

​

19,697

​

​

9,763

Total revenues

​

$

302,328

​

$

257,654

​

$

209,625

Schedule of total revenue by geographic area

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended December 31, 

​

​

2019

    

2018

    

2017

(Amounts in thousands)

​

​

​

​

​

​

​

United States

​

$

260,846

 

$

225,931

 

$

185,533

Americas, excluding U.S.

​

​

3,218

 

​

3,472

 

​

3,028

Europe, Middle East, India, Africa

​

​

15,434

 

​

20,866

 

​

13,998

Asia Pacific and Other

​

​

22,830

 

​

7,385

 

​

7,066

Total

​

$

302,328

 

$

257,654

​

$

209,625

Schedule of beginning and ending balances of accounts receivable and deferred revenues

​

​

​

​

​

​

​

​

​

​

Balance at

​

Balance at

​

​

December 31,

​

December 31,

​

​

2019

​

2018

(Amounts in thousands)

​

​

​

​

Assets:

​

​

​

​

​

​

Accounts receivable

​

$

53,351

​

$

62,223

Liabilities:

​

​

​

​

​

​

Deferred revenue, current portion

​

$

56,016

​

$

4,131

Deferred revenue, long-term portion

​

​

23,808

​

​

40,058

Total deferred revenues

​

$

79,824

​

$

44,189

Schedule of changes in the balance of deferred revenues

​

​

​

​

​

​

​

Deferred

​

​

Revenues

​

​

(in thousands)

Balance at December 31, 2018

​

$

44,189

Increase in deferred revenues

​

​

65,026

Revenue recognized during the period that was included in
deferred revenues at the beginning of the period

​

​

(970)

Revenue recognized from performance obligations satisfied
within the same period

​

​

(23,209)

Transferred in the sale of business

​

​

(5,212)

Balance at December 31, 2019

​

$

79,824

Schedule of insurance carrier reserve balance

​

​

​

​

​

​

​

​

​

    

December 31, 

    

December 31, 

​

    

2019

    

2018

​

​

​

​

​

​

​

(Amounts in thousands)

​

​

​

​

​

Beginning balance

​

$

10,012

​

$

6,795

Additional reserves

​

​

9,560

​

​

10,295

Reserves released

​

​

(10,162)

​

​

(7,078)

Ending balance

​

$

9,410

​

$

10,012

​

​

​

​

​

​

​

Released into revenue

​

$

2,410

​

$

3,324